Telescope Innovations Advances Self-Driving Lab Deployment, Strengthening Industry Impact
Telescope Innovations Corp (CSE: TELI) (OTCQB: TELIF) provides an update on its Self-Driving Lab (SDL) technology development. SDLs combine AI, robotics, and advanced chemistry analytics to accelerate R&D processes 10-100 times faster than traditional methods.
The company has strengthened its position through a master collaborative agreement with Pfizer and becoming a Certified Systems Integrator with Universal Robots. Telescope has expanded its team by 33% over the past six months, enhancing expertise in chemistry, engineering, robotics, and AI-driven automation.
CTO Prof. Jason Hein has engaged with leading institutions including Seoul National University and Korean institutes to strengthen international partnerships. The company focuses on accelerating research in pharmaceuticals, industrial chemicals, and critical minerals, positioning itself to create value in the AI-powered scientific landscape.
Telescope Innovations Corp (CSE: TELI) (OTCQB: TELIF) fornisce un aggiornamento sullo sviluppo della sua tecnologia Self-Driving Lab (SDL). Gli SDL combinano AI, robotica e analisi chimiche avanzate per accelerare i processi di R&D da 10 a 100 volte più veloci rispetto ai metodi tradizionali.
L'azienda ha rafforzato la sua posizione attraverso un accordo di collaborazione master con Pfizer e diventando un Certified Systems Integrator con Universal Robots. Telescope ha espanso il suo team del 33% negli ultimi sei mesi, aumentando l'expertise in chimica, ingegneria, robotica e automazione guidata dall'AI.
Il CTO Prof. Jason Hein ha collaborato con istituzioni di primo piano, tra cui l'Università Nazionale di Seoul e istituti coreani, per rafforzare le partnership internazionali. L'azienda si concentra sull'accelerazione della ricerca nei settori farmaceutico, chimico industriale e minerali critici, posizionandosi per creare valore nel panorama scientifico alimentato dall'AI.
Telescope Innovations Corp (CSE: TELI) (OTCQB: TELIF) proporciona una actualización sobre el desarrollo de su tecnología Self-Driving Lab (SDL). Los SDL combinan IA, robótica y análisis químicos avanzados para acelerar los procesos de I+D de 10 a 100 veces más rápido que los métodos tradicionales.
La empresa ha fortalecido su posición a través de un acuerdo de colaboración maestro con Pfizer y se ha convertido en un Certified Systems Integrator con Universal Robots. Telescope ha expandido su equipo en un 33% en los últimos seis meses, mejorando la experiencia en química, ingeniería, robótica y automatización impulsada por IA.
El CTO Prof. Jason Hein ha colaborado con instituciones líderes, incluyendo la Universidad Nacional de Seúl y otros institutos coreanos, para fortalecer las asociaciones internacionales. La empresa se centra en acelerar la investigación en farmacéuticos, productos químicos industriales y minerales críticos, posicionándose para crear valor en el panorama científico impulsado por la IA.
텔레스코프 이노베이션스 코프 (CSE: TELI) (OTCQB: TELIF)는 자율주행 연구실(Self-Driving Lab, SDL) 기술 개발에 대한 업데이트를 제공합니다. SDL은 AI, 로봇 공학 및 고급 화학 분석을 결합하여 연구 및 개발 프로세스를 전통적인 방법보다 10배에서 100배 더 빠르게 가속화합니다.
회사는 화이자와의 마스터 협력 계약을 체결하고 유니버설 로봇의 인증 시스템 통합자가 됨으로써 입지를 강화했습니다. 텔레스코프는 지난 6개월 동안 팀을 33% 확장했습니다, 화학, 엔지니어링, 로봇 공학 및 AI 기반 자동화 분야의 전문성을 강화했습니다.
CTO 제이슨 하인 교수는 서울대학교 및 한국의 주요 기관들과 협력하여 국제 파트너십을 강화했습니다. 이 회사는 제약, 산업 화학 및 중요한 광물 분야의 연구를 가속화하는 데 집중하고 있으며, AI 기반의 과학적 환경에서 가치를 창출할 수 있는 위치를 확보하고 있습니다.
Telescope Innovations Corp (CSE: TELI) (OTCQB: TELIF) fournit une mise à jour sur le développement de sa technologie de laboratoire autonome (Self-Driving Lab, SDL). Les SDL combinent l'IA, la robotique et des analyses chimiques avancées pour accélérer les processus de R&D de 10 à 100 fois plus rapidement que les méthodes traditionnelles.
L'entreprise a renforcé sa position grâce à un accord de collaboration maître avec Pfizer et est devenue un intégrateur de systèmes certifié avec Universal Robots. Telescope a élargi son équipe de 33% au cours des six derniers mois, renforçant son expertise en chimie, ingénierie, robotique et automatisation pilotée par l'IA.
Le CTO Prof. Jason Hein a collaboré avec des institutions de premier plan, y compris l'Université Nationale de Séoul et des instituts coréens, pour renforcer les partenariats internationaux. L'entreprise se concentre sur l'accélération de la recherche dans les domaines pharmaceutiques, des produits chimiques industriels et des minéraux critiques, se positionnant pour créer de la valeur dans le paysage scientifique alimenté par l'IA.
Telescope Innovations Corp (CSE: TELI) (OTCQB: TELIF) gibt ein Update zur Entwicklung seiner Self-Driving Lab (SDL) Technologie. SDLs kombinieren KI, Robotik und fortschrittliche chemische Analytik, um Forschungs- und Entwicklungsprozesse 10 bis 100 Mal schneller als traditionelle Methoden zu beschleunigen.
Das Unternehmen hat seine Position durch einen Master-Kooperationsvertrag mit Pfizer gestärkt und ist ein zertifizierter Systemintegrator bei Universal Robots geworden. Telescope hat sein Team in den letzten sechs Monaten um 33% erweitert und damit die Expertise in Chemie, Ingenieurwesen, Robotik und KI-gesteuerter Automatisierung verbessert.
CTO Prof. Jason Hein hat mit führenden Institutionen, darunter der Seoul National University und koreanischen Instituten, zusammengearbeitet, um internationale Partnerschaften zu stärken. Das Unternehmen konzentriert sich darauf, die Forschung in den Bereichen Pharmazie, industrielle Chemikalien und kritische Mineralien zu beschleunigen und sich in der KI-gesteuerten wissenschaftlichen Landschaft Wert zu schaffen.
- Partnership with major pharmaceutical company Pfizer through master collaborative agreement
- Certification as Systems Integrator with Universal Robots
- 33% team expansion in past 6 months
- Technology accelerates R&D processes up to 100x faster than traditional methods
- None.
Vancouver, British Columbia--(Newsfile Corp. - February 24, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company") is a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries. The Company is pleased to provide an update on its Self-Driving Lab ("SDL") technology, which integrates AI, robotics, advanced analytics, and chemistry to accelerate research and development.
Recent AI advancements highlight that ingenuity and adaptability-not just scale-drive innovation. Companies that strategically apply intelligent automation are leading the next wave of scientific progress, accelerating discovery while optimizing efficiency and cost. Telescope is at the forefront of this shift, applying its expertise to advance chemistry process development and crystallization optimization in pharmaceuticals, industrial chemicals, and critical minerals. With technology aligned to industry needs and a growing market presence, the Company is positioned to create significant value for stakeholders in the evolving AI-powered scientific landscape.
SELF-DRIVING LABS CUT TIME FROM DISCOVERY TO MARKET BY 10-100 X
Self-Driving Labs ("SDLs") combine artificial intelligence, robotic-based automation and advanced chemistry analytical technology (Fig. 1). By leveraging real-time data acquisition and machine learning, SDLs operate continuously running experiments, analyze results, and refine processes without the constraints of a traditional work schedule. SDLs optimize material properties, streamline chemical synthesis, and accelerate process development up to 100 times faster than traditional methods.[1] By enhancing productivity, reducing operational costs, and unlocking new possibilities in scientific exploration, SDLs work alongside researchers to reshape how high-value chemicals and pharmaceuticals are discovered, developed, and scaled for commercialization.
Figure 1. Self-Driving Labs (SDLs) combine artificial intelligence with robotic automation to accelerate R&D. SDLs provide key competitive advantages in the pharmaceutical and fine chemical industries.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8923/241857_7a46dc31f4fe5b01_001full.jpg
TELESCOPE DRIVES SDL INNOVATION WITH GLOBAL STAKEHOLDERS
Building on its master collaborative research agreement with Pfizer, Telescope continues to refine SDL technology and strategically position its SDLs for deployment within the pharmaceutical industry. Since becoming a Certified Systems Integrator with Universal Robots (UR) in October 2024, the Company has enhanced its automation capabilities, integrating collaborative robotics into SDL platforms to offer scalable solutions for global customers.
To further Telescope's impact, CTO Prof. Jason Hein has actively engaged with leading global institutions, including Seoul National University, the Korean Institute of Science and Technology, and the Korea Advanced Institute of Science & Technology. Through lectures and direct engagements, he has strengthened partnerships with top automation experts, reinforcing the Company's international presence and expanding its network within the world's most advanced robotics and research communities.
SCALING TALENT AND TECHNOLOGY TO MEET RISING DEMAND
Telescope has expanded its team by
A VISION FOR THE FUTURE
"Industries today face mounting pressure to innovate faster while reducing costs and resource consumption," said Henry Dubina, CEO of Telescope. "By integrating AI, robotics, and chemistry, we provide the tools necessary for companies to transform R&D, bringing new products to market with unprecedented speed and efficiency. Telescope is uniquely positioned to deliver scalable, high-impact solutions that create long-term value for both customers and investors. With strong industry adoption and an expanding market presence, we are leading the next wave of automation-driven innovation."
Jason Hein, CTO of Telescope, added, "Recent AI advancements have shown that innovation is no longer the exclusive domain of large corporations. Companies that effectively integrate AI, robotics, and chemistry are driving a new era of discovery, reducing costs, and accelerating commercialization. Our collaborations with top-tier research institutions and industry leaders ensure we are at the forefront of delivering technologies that redefine chemical research and manufacturing."
The Company's focus on integrating robotics and AI into real-world research applications ensures its technology delivers both scientific breakthroughs and scalable, revenue-generating opportunities for investors.
About Telescope Innovations
Telescope Innovations is a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. The Company builds and deploys new enabling technologies including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. Our aim is to bring modern chemical technology solutions to meet the most serious challenges in health and sustainability.
On behalf of the Board,
Telescope Innovations Corp.
Henry Dubina, Chief Executive Officer
E: hdubina@telescopeinn.com
Forward-Looking Information
Forward-looking information is based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, and uncertainties that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information.
The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
[1] (a) Ament, S. et al. Sci. Adv. 2021, 7(51) , eabg4930. (b) Macleod, P. et al.Nat. Commun. 2022, 13, 995.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/241857
FAQ
What is the potential speed improvement offered by Telescope's (TELIF) Self-Driving Labs?
How much has Telescope Innovations (TELIF) expanded its workforce in 2024-2025?
What major partnership does Telescope (TELIF) have in the pharmaceutical industry?
When did Telescope (TELIF) become a Certified Systems Integrator with Universal Robots?
Which international institutions has Telescope (TELIF) engaged with for partnerships?
